PYXS
Pyxis Oncology Inc
3.20$
-4.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -357.2% | -458.2% | |
| – | – | – | – | – | 18.5% | 32.6% | |
| – | – | – | – | – | 80.2% | 85.2% | |
| – | – | – | – | – | -73.2% | 14.0% | |
| – | – | – | – | – | 1.5% | 0.1% | |
| – | – | – | – | – | 50.5% | 424.7% | |
| – | – | – | – | – | 367.4% | 4.3% | |
| – | – | – | – | – | 60.8% | -29.2% | |
| – | – | – | – | – | -358.7% | -458.3% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.